A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 44
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : ANCA
Long Form : autoantibodies to neutrophil cytoplasmic antigens
No. Year Title Co-occurring Abbreviation
2019 [ANCA-associated vasculitides : State of the art]. AAV, GC, MPA
2018 Linked help from bacterial proteins drives autoantibody production in small vessel vasculitis. GPA, MPO, PR3
2015 Twenty-five years of European Union collaboration in ANCA-associated vasculitis research. ---
2013 [ANCA-associated vasculitis affecting lungs and kidneys: clinical and morphological characteristic, treatment, outcomes]. ---
2012 Azathioprine hypersensitivity presenting as cardiogenic shock and Sweet's syndrome in a patient with microscopic polyangiitis. ---
2009 Plasma exchange therapy in steroid-unresponsive relapses in patients with multiple sclerosis. CIDP, GBM, GBS, MS, PE, TTP
2008 CpG oligodeoxynucleotide stimulates production of anti-neutrophil cytoplasmic antibodies in ANCA associated vasculitis. ---
2008 Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. FNGN, LAMP-2
2007 Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. ---
10  2004 Autoantibodies to neutrophil cytoplasmic antigens (ANCA) do not bind to polymorphonuclear neutrophils in blood. PMN, PR3
11  2002 [Antineutrophil cytoplasmic antibodies in patients with diffuse diseases of connective tissue]. RA, SLE, SS
12  2000 T cell activation in patients with ANCA-associated vasculitis: inefficient immune suppression by therapy. sIL-2R
13  1999 An overlap syndrome with features of atypical Cogan syndrome and Wegener's granulomatosis. ---
14  1999 Heat treatment of normal human sera reveals antibodies to bactericidal permeability-inducing protein (BPI). BPI, GBM, MPO, PEG, PR3
15  1998 Anticytokeratins are a potential source of false-positive indirect immunofluorescence assays for C-ANCA. ---
16  1998 Semi-specific immuno-absorption and monoclonal antibody therapy in ANCA positive vasculitis: experience in four cases. IA, mAbs, MPO, PR3
17  1996 Antineutrophil cytoplasmic antibodies in myelodysplasia. c-ANCA, MPO, pANCA
18  1995 Antibodies to neutrophil cytoplasmic antigens induce monocyte chemoattractant protein-1 secretion from human monocytes. IgG, MCP-1
19  1994 Autoantibody associations with MHC class II antigens in scleroderma and autoimmune vasculitis. ACA, MPO, PR3
20  1994 Effect of anti-neutrophil cytoplasm autoantibodies on the intracellular calcium concentration of human neutrophils. PAF
21  1994 IgG subclass distribution and complement activation ability of autoantibodies to neutrophil cytoplasmic antigens (ANCA). ---
22  1994 [Hypersensitivity angiitis, Henoch-Schonlein purpura]. ---
23  1993 Anti-neutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus. SLE
24  1993 Are antibodies to neutrophilic cytoplasmic antigens (ANCA) a serologic marker for Sweet's syndrome? ---
25  1993 Neutrophil alloantibodies react with cytoplasmic antigens: a possible cause of false-positive indirect immunofluorescence assays for antibodies to neutrophil cytoplasmic antigens. ANCA-IF, C-ANCA
26  1993 p-ANCA of undefined specificity in ulcerative colitis: correlation to disease activity and therapy. CD, IBD, MPO, UC, WG
27  1993 Serum soluble interleukin 2 receptor levels in anti-neutrophil cytoplasmic autoantibodies--positive systemic vasculitis. sIL-2R
28  1993 Vasculitis--an overview. ---
29  1993 [Anti-neutrophil-cytoplasmic antibodies in rheumatoid arthritis: specificity and clinical relevance?]. ANA, CRP, MPO, RA
30  1992 Autoantibodies to leucocyte antigens in hydralazine-associated nephritis. ANA, anti-MPO
31  1992 Autoantibodies to neutrophil cytoplasmic (ANCA) and endothelial cell surface antigens (AECA) in chronic inflammatory bowel disease. IBD, IIF, MPO, P-ANCA, UC
32  1992 T and B cell responses to neutrophil cytoplasmic antigens in systemic vasculitis. MPO, PBLs, SV
33  1992 Wegener's granulomatosis--treatment under revision? ---
34  1992 [A new type of ANCA in sera of patients with ulcerative colitis: effects of therapy and disease severity on serum titer]. IBD, p-ANCA, UC, WG
35  1991 Antineutrophil cytoplasmic autoantibody-associated diseases: a rheumatologist's perspective. IF, SLE, WG
36  1991 Autoantibodies to neutrophil cytoplasm (ANCA) in Wegener's granulomatosis. Clinical significance and antigen specificity. ---
37  1991 Autoimmunity to lysosomal enzymes: new clues to vasculitis and glomerulonephritis? ---
38  1991 Diagnosis and management of systemic Wegener's granulomatosis presenting with anterior ocular inflammatory disease. ---
39  1991 Occurrence of autoantibodies against neutrophil granulocyte components in juvenile chronic arthritis. ANA, GS-ANA
40  1990 A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease. ANA, CD, IBD, p-ANCA, pANCA, UC, WG
41  1990 Antibodies directed against neutrophils (C-ANCA and P-ANCA) are of distinct diagnostic value in systemic vasculitis. ---
42  1989 Antibodies to neutrophil cytoplasmic antigens in Wegener's granulomatosis and other conditions. ---
43  1989 Autoantibodies to neutrophil cytoplasmic antigens in systemic vasculitis have the same target specificity. ---
44  1989 Severe pulmonary hemorrhage and systemic vasculitis in association with circulating anti-neutrophil cytoplasm antibodies of IgM class only. SPRIA